Collegium to Participate in Upcoming Investor Conferences
Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in two upcoming investor conferences. The company will engage in fireside chats at the Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. GMT and the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024, at 1:00 p.m. ET. Both sessions will be accessible via webcast through the company's investor relations website, with recordings available for 90 days post-presentation.
Collegium Pharmaceutical (Nasdaq: COLL) ha annunciato la sua partecipazione a due prossimi conferenze per investitori. La società parteciperà a conversazioni informali durante il Jefferies London Healthcare Conference il 19 novembre 2024, alle 13:30 GMT e il Piper Sandler 36th Annual Healthcare Conference il 5 dicembre 2024, alle 13:00 ET. Entrambi gli eventi saranno accessibili tramite webcast attraverso il sito web delle relazioni con gli investitori dell'azienda, con registrazioni disponibili per 90 giorni dopo la presentazione.
Collegium Pharmaceutical (Nasdaq: COLL) ha anunciado su participación en dos próximas conferencias para inversores. La empresa participará en charlas informales en la Jefferies London Healthcare Conference el 19 de noviembre de 2024, a la 1:30 p.m. GMT y en la Piper Sandler 36th Annual Healthcare Conference el 5 de diciembre de 2024, a la 1:00 p.m. ET. Ambas sesiones estarán disponibles a través de un webcast en el sitio web de relaciones con inversores de la compañía, con grabaciones disponibles durante 90 días después de la presentación.
Collegium Pharmaceutical (Nasdaq: COLL)이 두 개의 다가오는 투자자 콘퍼런스에 참가한다고 발표했습니다. 이 회사는 2024년 11월 19일 오후 1시 30분 GMT에 열리는 제퍼리스 런던 헬스케어 컨퍼런스와 2024년 12월 5일 오후 1시 EST에 열리는 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에서 파이어사이드 챗에 참여할 예정입니다. 두 세션 모두 회사의 투자자 관계 웹사이트를 통해 웹캐스트로 이용 가능하며, 발표 후 90일 동안 녹화된 내용이 제공됩니다.
Collegium Pharmaceutical (Nasdaq: COLL) a annoncé sa participation à deux conférences pour investisseurs à venir. L'entreprise participera à des discussions informelles lors de la Jefferies London Healthcare Conference le 19 novembre 2024 à 13h30 GMT et à la Piper Sandler 36e Conférence Annuelle sur la Santé le 5 décembre 2024 à 13h00 ET. Les deux sessions seront accessibles par webcast via le site Web des relations investisseurs de l'entreprise, avec des enregistrements disponibles pendant 90 jours après la présentation.
Collegium Pharmaceutical (Nasdaq: COLL) hat die Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird am 19. November 2024 um 13:30 Uhr GMT an informellen Gesprächen auf der Jefferies London Healthcare Conference und am 5. Dezember 2024 um 13:00 Uhr ET bei der Piper Sandler 36. jährlichen Gesundheitskonferenz teilnehmen. Beide Sitzungen werden über Webcast über die Investor-Relations-Website des Unternehmens zugänglich sein, mit Aufzeichnungen, die 90 Tage nach der Präsentation verfügbar sind.
- None.
- None.
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
FAQ
When is Collegium Pharmaceutical (COLL) presenting at the Jefferies London Healthcare Conference 2024?
What time is Collegium's (COLL) fireside chat at the Piper Sandler Healthcare Conference 2024?
How long will Collegium's (COLL) investor conference webcasts be available for replay?
Where can I watch Collegium Pharmaceutical's (COLL) investor conference presentations?
